Study S000824

Liraglutide Effectiveness and Safety Data From Routine Clinical Practice in Philippines Study. A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes Mellitus in Philippines

ClinicalTrials.gov record

Registration

Registration: NCT01345734
Acronym: Lead-Ph
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 1056
Start: 2011-09-01
Primary completion: 2013-07-26
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: DRUG:liraglutide
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1119-8803

Registered primary outcomes

Incidence of serious adverse drug reactions (SADRs) [Week 0, week 26]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025628	The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes. Jimeno C, Journal of the ASEAN Federation of Endocrine Societies	2018	Nonrandomized study	PMID 33442116 DOI	registry reference RESULT:33442116